Janet Veatch

1.1k total citations
9 papers, 730 citations indexed

About

Janet Veatch is a scholar working on Neurology, Cancer Research and Surgery. According to data from OpenAlex, Janet Veatch has authored 9 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 7 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Janet Veatch's work include Neuroblastoma Research and Treatments (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Cancer therapeutics and mechanisms (3 papers). Janet Veatch is often cited by papers focused on Neuroblastoma Research and Treatments (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Cancer therapeutics and mechanisms (3 papers). Janet Veatch collaborates with scholars based in United States. Janet Veatch's co-authors include Katherine K. Matthay, John P. Huberty, John M. Maris, Randall A. Hawkins, Gregory A. Yanik, Julia A. Messina, Robert E. Goldsby, Alekist Quach, David V. Glidden and David C. Price and has published in prestigious journals such as Journal of Clinical Oncology, Annals of the New York Academy of Sciences and International Journal of Cancer.

In The Last Decade

Janet Veatch

9 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janet Veatch United States 8 536 341 248 194 125 9 730
Veronica Tavaglione Italy 8 132 0.2× 106 0.3× 125 0.5× 67 0.3× 216 1.7× 8 460
Shipra Agarwal India 13 53 0.1× 64 0.2× 207 0.8× 107 0.6× 96 0.8× 83 616
S. Hescot France 15 46 0.1× 222 0.7× 285 1.1× 54 0.3× 68 0.5× 48 604
Alexander Weich Germany 12 132 0.2× 54 0.2× 86 0.3× 81 0.4× 205 1.6× 48 582
Sheila Lindsay United States 12 81 0.2× 53 0.2× 117 0.5× 88 0.5× 136 1.1× 19 569
J E Westlin Sweden 9 121 0.2× 75 0.2× 90 0.4× 35 0.2× 182 1.5× 18 514
Zeynep Gözde Özkan Türkiye 14 68 0.1× 92 0.3× 111 0.4× 47 0.2× 131 1.0× 40 518
Isamu Hayashi Japan 12 49 0.1× 119 0.3× 128 0.5× 112 0.6× 74 0.6× 20 507
N. Fehse Germany 8 157 0.3× 64 0.2× 42 0.2× 149 0.8× 66 0.5× 11 595
M. Papotti Italy 8 64 0.1× 274 0.8× 83 0.3× 310 1.6× 116 0.9× 12 783

Countries citing papers authored by Janet Veatch

Since Specialization
Citations

This map shows the geographic impact of Janet Veatch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Veatch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Veatch more than expected).

Fields of papers citing papers by Janet Veatch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Veatch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Veatch. The network helps show where Janet Veatch may publish in the future.

Co-authorship network of co-authors of Janet Veatch

This figure shows the co-authorship network connecting the top 25 collaborators of Janet Veatch. A scholar is included among the top collaborators of Janet Veatch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet Veatch. Janet Veatch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Quach, Alekist, Lingyun Ji, Vikash Kumar Mishra, et al.. (2010). Thyroid and hepatic function after high‐dose 131I‐metaiodobenzylguanidine (131I‐MIBG) therapy for neuroblastoma. Pediatric Blood & Cancer. 56(2). 191–201. 44 indexed citations
2.
Matthay, Katherine K., Alekist Quach, John P. Huberty, et al.. (2009). Iodine-131—Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study. Journal of Clinical Oncology. 27(7). 1020–1025. 79 indexed citations
3.
Matthay, Katherine K., Gregory A. Yanik, Julia A. Messina, et al.. (2007). Phase II Study on the Effect of Disease Sites, Age, and Prior Therapy on Response to Iodine-131-Metaiodobenzylguanidine Therapy in Refractory Neuroblastoma. Journal of Clinical Oncology. 25(9). 1054–1060. 173 indexed citations
4.
FitzGerald, Paul A., Robert E. Goldsby, John P. Huberty, et al.. (2006). Malignant Pheochromocytomas and Paragangliomas. Annals of the New York Academy of Sciences. 1073(1). 465–490. 95 indexed citations
5.
Matthay, K. K., Alekist Quach, John P. Huberty, et al.. (2006). 131I-Metaiodobenzylguanidine (131I-MIBG) double infusion with autologous stem cell transplant for neuroblastoma: A New Approaches to Neuroblastoma Therapy (NANT) study. Journal of Clinical Oncology. 24(18_suppl). 9011–9011. 2 indexed citations
6.
7.
DuBois, Steven G., Julia A. Messina, John M. Maris, et al.. (2004). Hematologic Toxicity of High-Dose Iodine-131–Metaiodobenzylguanidine Therapy for Advanced Neuroblastoma. Journal of Clinical Oncology. 22(12). 2452–2460. 78 indexed citations
8.
Matthay, Katherine K., John P. Huberty, David C. Price, et al.. (2001). Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.. PubMed. 42(11). 1713–21. 121 indexed citations
9.
Challinor, Julia, Christine Miaskowski, Linda S. Franck, et al.. (1999). Somatization, anxiety and depression as measures of health-related quality of life of children/adolescents with cancer. International Journal of Cancer. 83(S12). 52–57. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026